Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells

Human cytomegalovirus (HCMV) latency is typically harmless but reactivation can be largely detrimental to immune compromised hosts. We modeled latency and reactivation using a traceable HCMV laboratory strain expressing the Gaussia luciferase reporter gene (HCMV/GLuc) in order to interrogate the vir...

Full description

Bibliographic Details
Main Authors: Sebastian J. Theobald, Sahamoddin Khailaie, Michael Meyer-Hermann, Valery Volk, Henning Olbrich, Simon Danisch, Laura Gerasch, Andreas Schneider, Christian Sinzger, Dirk Schaudien, Stefan Lienenklaus, Peggy Riese, Carlos A. Guzman, Constanca Figueiredo, Constantin von Kaisenberg, Loukia M. Spineli, Stephanie Glaesener, Almut Meyer-Bahlburg, Arnold Ganser, Michael Schmitt, Michael Mach, Martin Messerle, Renata Stripecke
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02734/full
_version_ 1811233242024509440
author Sebastian J. Theobald
Sebastian J. Theobald
Sebastian J. Theobald
Sahamoddin Khailaie
Michael Meyer-Hermann
Michael Meyer-Hermann
Valery Volk
Valery Volk
Henning Olbrich
Henning Olbrich
Henning Olbrich
Simon Danisch
Simon Danisch
Simon Danisch
Laura Gerasch
Laura Gerasch
Andreas Schneider
Andreas Schneider
Christian Sinzger
Dirk Schaudien
Stefan Lienenklaus
Peggy Riese
Carlos A. Guzman
Constanca Figueiredo
Constantin von Kaisenberg
Loukia M. Spineli
Stephanie Glaesener
Almut Meyer-Bahlburg
Arnold Ganser
Michael Schmitt
Michael Mach
Martin Messerle
Martin Messerle
Renata Stripecke
Renata Stripecke
Renata Stripecke
author_facet Sebastian J. Theobald
Sebastian J. Theobald
Sebastian J. Theobald
Sahamoddin Khailaie
Michael Meyer-Hermann
Michael Meyer-Hermann
Valery Volk
Valery Volk
Henning Olbrich
Henning Olbrich
Henning Olbrich
Simon Danisch
Simon Danisch
Simon Danisch
Laura Gerasch
Laura Gerasch
Andreas Schneider
Andreas Schneider
Christian Sinzger
Dirk Schaudien
Stefan Lienenklaus
Peggy Riese
Carlos A. Guzman
Constanca Figueiredo
Constantin von Kaisenberg
Loukia M. Spineli
Stephanie Glaesener
Almut Meyer-Bahlburg
Arnold Ganser
Michael Schmitt
Michael Mach
Martin Messerle
Martin Messerle
Renata Stripecke
Renata Stripecke
Renata Stripecke
author_sort Sebastian J. Theobald
collection DOAJ
description Human cytomegalovirus (HCMV) latency is typically harmless but reactivation can be largely detrimental to immune compromised hosts. We modeled latency and reactivation using a traceable HCMV laboratory strain expressing the Gaussia luciferase reporter gene (HCMV/GLuc) in order to interrogate the viral modulatory effects on the human adaptive immunity. Humanized mice with long-term (more than 17 weeks) steady human T and B cell immune reconstitutions were infected with HCMV/GLuc and 7 weeks later were further treated with granulocyte-colony stimulating factor (G-CSF) to induce viral reactivations. Whole body bio-luminescence imaging analyses clearly differentiated mice with latent viral infections vs. reactivations. Foci of vigorous viral reactivations were detectable in liver, lymph nodes and salivary glands. The number of viral genome copies in various tissues increased upon reactivations and were detectable in sorted human CD14+, CD169+, and CD34+ cells. Compared with non-infected controls, mice after infections and reactivations showed higher thymopoiesis, systemic expansion of Th, CTL, Treg, and Tfh cells and functional antiviral T cell responses. Latent infections promoted vast development of memory CD4+ T cells while reactivations triggered a shift toward effector T cells expressing PD-1. Further, reactivations prompted a marked development of B cells, maturation of IgG+ plasma cells, and HCMV-specific antibody responses. Multivariate statistical methods were employed using T and B cell immune phenotypic profiles obtained with cells from several tissues of individual mice. The data was used to identify combinations of markers that could predict an HCMV infection vs. reactivation status. In spleen, but not in lymph nodes, higher frequencies of effector CD4+ T cells expressing PD-1 were among the factors most suited to distinguish HCMV reactivations from infections. These results suggest a shift from a T cell dominated immune response during latent infections toward an exhausted T cell phenotype and active humoral immune response upon reactivations. In sum, this novel in vivo humanized model combined with advanced analyses highlights a dynamic system clearly specifying the immunological spatial signatures of HCMV latency and reactivations. These signatures can be merged as predictive biomarker clusters that can be applied in the clinical translation of new therapies for the control of HCMV reactivation.
first_indexed 2024-04-12T11:17:42Z
format Article
id doaj.art-2f391d38b86f4d808225f222366bbfad
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T11:17:42Z
publishDate 2018-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-2f391d38b86f4d808225f222366bbfad2022-12-22T03:35:27ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-11-01910.3389/fimmu.2018.02734418849Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ CellsSebastian J. Theobald0Sebastian J. Theobald1Sebastian J. Theobald2Sahamoddin Khailaie3Michael Meyer-Hermann4Michael Meyer-Hermann5Valery Volk6Valery Volk7Henning Olbrich8Henning Olbrich9Henning Olbrich10Simon Danisch11Simon Danisch12Simon Danisch13Laura Gerasch14Laura Gerasch15Andreas Schneider16Andreas Schneider17Christian Sinzger18Dirk Schaudien19Stefan Lienenklaus20Peggy Riese21Carlos A. Guzman22Constanca Figueiredo23Constantin von Kaisenberg24Loukia M. Spineli25Stephanie Glaesener26Almut Meyer-Bahlburg27Arnold Ganser28Michael Schmitt29Michael Mach30Martin Messerle31Martin Messerle32Renata Stripecke33Renata Stripecke34Renata Stripecke35Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, GermanyExcellence Cluster REBIRTH, Laboratory of Regenerative Immune Therapies Applied, Hannover Medical School, Hannover, GermanyPartner Site Hannover-Braunschweig, German Center for Infection Research (DZIF), Braunschweig, GermanyDepartment of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, GermanyDepartment of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, GermanyInstitute for Biochemistry, Biotechnology and Bioinformatics, Technical University Braunschweig, Braunschweig, GermanyClinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, GermanyExcellence Cluster REBIRTH, Laboratory of Regenerative Immune Therapies Applied, Hannover Medical School, Hannover, GermanyClinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, GermanyExcellence Cluster REBIRTH, Laboratory of Regenerative Immune Therapies Applied, Hannover Medical School, Hannover, GermanyPartner Site Hannover-Braunschweig, German Center for Infection Research (DZIF), Braunschweig, GermanyClinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, GermanyExcellence Cluster REBIRTH, Laboratory of Regenerative Immune Therapies Applied, Hannover Medical School, Hannover, GermanyPartner Site Hannover-Braunschweig, German Center for Infection Research (DZIF), Braunschweig, GermanyClinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, GermanyExcellence Cluster REBIRTH, Laboratory of Regenerative Immune Therapies Applied, Hannover Medical School, Hannover, GermanyClinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, GermanyExcellence Cluster REBIRTH, Laboratory of Regenerative Immune Therapies Applied, Hannover Medical School, Hannover, GermanyInstitute of Virology, University of Ulm, Ulm, GermanyFraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, GermanyInstitute for Laboratory Animal Science, Hannover Medical School, Hannover, GermanyDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research Braunschweig, Braunschweig, GermanyDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research Braunschweig, Braunschweig, Germany0Department of Transfusion Medicine, Hannover Medical School, Hannover, Germany1Clinic of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany2Institute for Biostatistics, Hannover Medical School, Hannover, GermanyClinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany3Department of Pediatrics, University Medicine Greifswald, Greifswald, GermanyClinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany4Department of Hematology, Oncology and Rheumatology, GMP Core Facility, Heidelberg University Hospital, Heidelberg, Germany5Institute of Virology, University Erlangen-Nürnberg, Erlangen, GermanyPartner Site Hannover-Braunschweig, German Center for Infection Research (DZIF), Braunschweig, Germany6Institute of Virology, Hannover Medical School, Hannover, GermanyClinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, GermanyExcellence Cluster REBIRTH, Laboratory of Regenerative Immune Therapies Applied, Hannover Medical School, Hannover, GermanyPartner Site Hannover-Braunschweig, German Center for Infection Research (DZIF), Braunschweig, GermanyHuman cytomegalovirus (HCMV) latency is typically harmless but reactivation can be largely detrimental to immune compromised hosts. We modeled latency and reactivation using a traceable HCMV laboratory strain expressing the Gaussia luciferase reporter gene (HCMV/GLuc) in order to interrogate the viral modulatory effects on the human adaptive immunity. Humanized mice with long-term (more than 17 weeks) steady human T and B cell immune reconstitutions were infected with HCMV/GLuc and 7 weeks later were further treated with granulocyte-colony stimulating factor (G-CSF) to induce viral reactivations. Whole body bio-luminescence imaging analyses clearly differentiated mice with latent viral infections vs. reactivations. Foci of vigorous viral reactivations were detectable in liver, lymph nodes and salivary glands. The number of viral genome copies in various tissues increased upon reactivations and were detectable in sorted human CD14+, CD169+, and CD34+ cells. Compared with non-infected controls, mice after infections and reactivations showed higher thymopoiesis, systemic expansion of Th, CTL, Treg, and Tfh cells and functional antiviral T cell responses. Latent infections promoted vast development of memory CD4+ T cells while reactivations triggered a shift toward effector T cells expressing PD-1. Further, reactivations prompted a marked development of B cells, maturation of IgG+ plasma cells, and HCMV-specific antibody responses. Multivariate statistical methods were employed using T and B cell immune phenotypic profiles obtained with cells from several tissues of individual mice. The data was used to identify combinations of markers that could predict an HCMV infection vs. reactivation status. In spleen, but not in lymph nodes, higher frequencies of effector CD4+ T cells expressing PD-1 were among the factors most suited to distinguish HCMV reactivations from infections. These results suggest a shift from a T cell dominated immune response during latent infections toward an exhausted T cell phenotype and active humoral immune response upon reactivations. In sum, this novel in vivo humanized model combined with advanced analyses highlights a dynamic system clearly specifying the immunological spatial signatures of HCMV latency and reactivations. These signatures can be merged as predictive biomarker clusters that can be applied in the clinical translation of new therapies for the control of HCMV reactivation.https://www.frontiersin.org/article/10.3389/fimmu.2018.02734/fullHCMVreactivationhumanized miceT cell maturationB cell class switchoptical imaging analyses
spellingShingle Sebastian J. Theobald
Sebastian J. Theobald
Sebastian J. Theobald
Sahamoddin Khailaie
Michael Meyer-Hermann
Michael Meyer-Hermann
Valery Volk
Valery Volk
Henning Olbrich
Henning Olbrich
Henning Olbrich
Simon Danisch
Simon Danisch
Simon Danisch
Laura Gerasch
Laura Gerasch
Andreas Schneider
Andreas Schneider
Christian Sinzger
Dirk Schaudien
Stefan Lienenklaus
Peggy Riese
Carlos A. Guzman
Constanca Figueiredo
Constantin von Kaisenberg
Loukia M. Spineli
Stephanie Glaesener
Almut Meyer-Bahlburg
Arnold Ganser
Michael Schmitt
Michael Mach
Martin Messerle
Martin Messerle
Renata Stripecke
Renata Stripecke
Renata Stripecke
Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells
Frontiers in Immunology
HCMV
reactivation
humanized mice
T cell maturation
B cell class switch
optical imaging analyses
title Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells
title_full Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells
title_fullStr Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells
title_full_unstemmed Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells
title_short Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells
title_sort signatures of t and b cell development functional responses and pd 1 upregulation after hcmv latent infections and reactivations in nod rag gamma mice humanized with cord blood cd34 cells
topic HCMV
reactivation
humanized mice
T cell maturation
B cell class switch
optical imaging analyses
url https://www.frontiersin.org/article/10.3389/fimmu.2018.02734/full
work_keys_str_mv AT sebastianjtheobald signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT sebastianjtheobald signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT sebastianjtheobald signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT sahamoddinkhailaie signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT michaelmeyerhermann signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT michaelmeyerhermann signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT valeryvolk signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT valeryvolk signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT henningolbrich signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT henningolbrich signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT henningolbrich signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT simondanisch signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT simondanisch signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT simondanisch signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT lauragerasch signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT lauragerasch signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT andreasschneider signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT andreasschneider signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT christiansinzger signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT dirkschaudien signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT stefanlienenklaus signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT peggyriese signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT carlosaguzman signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT constancafigueiredo signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT constantinvonkaisenberg signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT loukiamspineli signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT stephanieglaesener signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT almutmeyerbahlburg signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT arnoldganser signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT michaelschmitt signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT michaelmach signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT martinmesserle signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT martinmesserle signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT renatastripecke signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT renatastripecke signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells
AT renatastripecke signaturesoftandbcelldevelopmentfunctionalresponsesandpd1upregulationafterhcmvlatentinfectionsandreactivationsinnodraggammamicehumanizedwithcordbloodcd34cells